Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

COVID-19 × Atorvastatin × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 15 Prostatic Neoplasms 10 Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Myeloid, Acute 4 Triple Negative Breast Neoplasms 3 Ovarian Neoplasms 3 Myelodysplastic Syndromes 3 Endometrial Neoplasms 3 Colorectal Neoplasms 3 Colonic Neoplasms 3 Cardiovascular Diseases 3 Cardiotoxicity 3 Rectal Neoplasms 2 Polycystic Ovary Syndrome 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Leukemia 2 Kidney Neoplasms 2 Heart Failure 2 Head and Neck Neoplasms 2 Glioblastoma 2 Endometrial Hyperplasia 2 Carcinoma, Renal Cell 2 Waldenstrom Macroglobulinemia 1 Venous Thrombosis 1 Urogenital Neoplasms 1 Smoking 1

Interventions

Standard of Care 8 Surveys and Questionnaires 7 COVID-19 Vaccines 6 Blood Specimen Collection 6 BNT162 Vaccine 6 Specimen Handling 5 2019-nCoV Vaccine mRNA-1273 5 Hydroxychloroquine 4 Surgical Procedures, Operative 3 Practice Guidelines as Topic 3 tocilizumab 2 sotrovimab 2 sinovac COVID-19 vaccine 2 cilgavimab and tixagevimab drug combination 2 Sodium Chloride 2 Pandemic Preparedness 2 Data Collection 2 CVnCoV COVID-19 vaccine 2 COH04S1 COVID-19 vaccine 2 Azithromycin 2 selinexor 1 remdesivir 1 regorafenib 1 proxalutamide 1 palbociclib 1 ogalvibart 1 monalizumab 1 lenzilumab 1 heterologous prime boost COVID-19 vaccination 1 crexavibart 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04904536 2025-04-10

STRONGER

The George Institute

Phase 3 Active not recruiting

COVID-19, Lymphoma, Follicular, Neurologic Manifestations

Data powered by HemOnc (CC BY 4.0) Colophon ⚡